Physicians' judgments about estrogen replacement therapy for menopausal women

Gerald B. Holzman, Michael M. Ravitch, William Metheny, Marilyn L. Rothert, Margaret Holmes, Ruth B. Hoppe

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

A study was undertaken to determine how physicians decide when to prescribe estrogen. Twenty-five gynecologists and 25 family physicians responded to case histories and a questionnaire regarding estrogen administration. There was no difference in mean probability of prescribing, 0.42 for gynecologists and 0.40 for family physicians. Endometrial cancer risk and vasomotor symptom severity were significant factors in prescribing judgments; osteoporosis risk and current treatment status were not. In linear regression analysis the constant, not factor weights, were significantly related to each physician's overall likelihood of prescribing and to the individual's self-characterization as presoiber or nonprescriber. Most physicians indicated that estrogen reduces fracture risk, and that progestin reduces cancer risk. Physicians' responses to cases were not consistent with these stated beliefs about estrogen effects.

Original languageEnglish (US)
Pages (from-to)303-311
Number of pages9
JournalObstetrics and gynecology
Volume63
Issue number3
StatePublished - Jan 1 1984

Fingerprint

Estrogen Replacement Therapy
Estrogens
Physicians
Family Physicians
Progestins
Endometrial Neoplasms
Osteoporosis
Linear Models
Regression Analysis
Weights and Measures
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

Holzman, G. B., Ravitch, M. M., Metheny, W., Rothert, M. L., Holmes, M., & Hoppe, R. B. (1984). Physicians' judgments about estrogen replacement therapy for menopausal women. Obstetrics and gynecology, 63(3), 303-311.

Physicians' judgments about estrogen replacement therapy for menopausal women. / Holzman, Gerald B.; Ravitch, Michael M.; Metheny, William; Rothert, Marilyn L.; Holmes, Margaret; Hoppe, Ruth B.

In: Obstetrics and gynecology, Vol. 63, No. 3, 01.01.1984, p. 303-311.

Research output: Contribution to journalArticle

Holzman, GB, Ravitch, MM, Metheny, W, Rothert, ML, Holmes, M & Hoppe, RB 1984, 'Physicians' judgments about estrogen replacement therapy for menopausal women', Obstetrics and gynecology, vol. 63, no. 3, pp. 303-311.
Holzman GB, Ravitch MM, Metheny W, Rothert ML, Holmes M, Hoppe RB. Physicians' judgments about estrogen replacement therapy for menopausal women. Obstetrics and gynecology. 1984 Jan 1;63(3):303-311.
Holzman, Gerald B. ; Ravitch, Michael M. ; Metheny, William ; Rothert, Marilyn L. ; Holmes, Margaret ; Hoppe, Ruth B. / Physicians' judgments about estrogen replacement therapy for menopausal women. In: Obstetrics and gynecology. 1984 ; Vol. 63, No. 3. pp. 303-311.
@article{0e76ffcb5fa041e8bed83cdca5dfe0a4,
title = "Physicians' judgments about estrogen replacement therapy for menopausal women",
abstract = "A study was undertaken to determine how physicians decide when to prescribe estrogen. Twenty-five gynecologists and 25 family physicians responded to case histories and a questionnaire regarding estrogen administration. There was no difference in mean probability of prescribing, 0.42 for gynecologists and 0.40 for family physicians. Endometrial cancer risk and vasomotor symptom severity were significant factors in prescribing judgments; osteoporosis risk and current treatment status were not. In linear regression analysis the constant, not factor weights, were significantly related to each physician's overall likelihood of prescribing and to the individual's self-characterization as presoiber or nonprescriber. Most physicians indicated that estrogen reduces fracture risk, and that progestin reduces cancer risk. Physicians' responses to cases were not consistent with these stated beliefs about estrogen effects.",
author = "Holzman, {Gerald B.} and Ravitch, {Michael M.} and William Metheny and Rothert, {Marilyn L.} and Margaret Holmes and Hoppe, {Ruth B.}",
year = "1984",
month = "1",
day = "1",
language = "English (US)",
volume = "63",
pages = "303--311",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Physicians' judgments about estrogen replacement therapy for menopausal women

AU - Holzman, Gerald B.

AU - Ravitch, Michael M.

AU - Metheny, William

AU - Rothert, Marilyn L.

AU - Holmes, Margaret

AU - Hoppe, Ruth B.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - A study was undertaken to determine how physicians decide when to prescribe estrogen. Twenty-five gynecologists and 25 family physicians responded to case histories and a questionnaire regarding estrogen administration. There was no difference in mean probability of prescribing, 0.42 for gynecologists and 0.40 for family physicians. Endometrial cancer risk and vasomotor symptom severity were significant factors in prescribing judgments; osteoporosis risk and current treatment status were not. In linear regression analysis the constant, not factor weights, were significantly related to each physician's overall likelihood of prescribing and to the individual's self-characterization as presoiber or nonprescriber. Most physicians indicated that estrogen reduces fracture risk, and that progestin reduces cancer risk. Physicians' responses to cases were not consistent with these stated beliefs about estrogen effects.

AB - A study was undertaken to determine how physicians decide when to prescribe estrogen. Twenty-five gynecologists and 25 family physicians responded to case histories and a questionnaire regarding estrogen administration. There was no difference in mean probability of prescribing, 0.42 for gynecologists and 0.40 for family physicians. Endometrial cancer risk and vasomotor symptom severity were significant factors in prescribing judgments; osteoporosis risk and current treatment status were not. In linear regression analysis the constant, not factor weights, were significantly related to each physician's overall likelihood of prescribing and to the individual's self-characterization as presoiber or nonprescriber. Most physicians indicated that estrogen reduces fracture risk, and that progestin reduces cancer risk. Physicians' responses to cases were not consistent with these stated beliefs about estrogen effects.

UR - http://www.scopus.com/inward/record.url?scp=0021338706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021338706&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 303

EP - 311

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -